Presentations

BioVie Company Overview

Developing Transformative Therapies to Overcome Chronic Debilitating Diseases.
Corporate Presentation • April 2022

BioVie KOL Webinar

Complications of Advanced Liver Cirrhosis and BIV-201 Phase 2b Clinical Trial Update.
Thur., Nov. 11th from 1:00 – 2:30 PM EDT

(Requires Login)

BioVie KOL Webinar

Neuroinflammation and Insulin Resistance and New Treatment Approaches for Alzheimer’s Disease (AD).
Tue., Oct. 26th, 2021

(Requires Login)

NE3107 Featured in the American Diabetes Association's Thought Leadership Film Series

Play Video about BioVie interview on Bloomberg Television US on the RedChip Money Report®

BioVie interview on Bloomberg Television US on the RedChip Money Report®

BioVie hosting Research & Development Day

Wed., May 19th, 2021

(Requires Login)

Have a Question/Comment?

Forward Looking Statements

This website contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties, and assumptions that could cause BioVie’s actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements.

For Forward Looking Statements, click below:

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Presentations

Presentations

BioVie Company Overview

BioVie KOL Webinar

BioVie KOL Webinar

NE3107 Featured in the American Diabetes Association's Thought Leadership Film Series

BioVie interview on Bloomberg Television US on the RedChip Money Report®

BioVie hosting Research & Development Day

Participate in Clinical Research

Volunteer for research studies to learn about your condition, gain access to new treatments and medications, and contribute to medical advancements.

Have a Question/Comment?

Forward Looking Statements